Peripheral Vascular Disease (PVD) Treatment: Options & Approaches

Peripheral vascular disease (PVD)—atherosclerotic narrowing of arteries outside the heart—requires a stepwise, individualized approach.

1. Lifestyle Modification (Foundation)

  • Smoking cessation: Single most impactful intervention; doubles amputation-free survival.
  • Supervised exercise therapy (SET): 30–45 min treadmill walking, 3×/week for 12+ weeks; improves claudication distance by 150–300%.
  • Heart-healthy diet: Mediterranean/DASH; low saturated fat, high fiber.
  • Weight management: BMI 18.5–24.9.
  • Glycemic control: HbA1c <7% for diabetics.
  • Blood pressure target: <130/80 mmHg.
  • Lipid management: High-intensity statin (LDL <70 mg/dL, or <55 mg/dL very high risk).

2. Pharmacotherapy

  • Antiplatelet: Aspirin 81 mg or clopidogrel 75 mg daily.
  • Statin: As above.
  • ACEi/ARB: For hypertension, diabetes, CKD; reduces cardiovascular events.
  • Cilostazol 100 mg BID: Improves walking distance (contraindicated in heart failure).
  • Anticoagulation: Not routine; consider rivaroxaban 2.5 mg BID + aspirin per VOYAGER PAD trial for post-revascularization.

3. Endovascular Intervention

  • Angioplasty ± stenting: Focal lesions, TASC A/B.
  • Atherectomy: Calcified lesions (adjunct).
  • Drug-coated balloons/stents: Reduce restenosis.

4. Surgical Revascularization

  • Bypass grafting: Long occlusions, TASC C/D, failed endo; autologous vein preferred.
  • Endarterectomy: Common femoral disease.

5. Critical Limb Ischemia (CLI)

Rest pain, ulcer, gangrene → urgent revascularization (endo or open) + wound care + antibiotics + multidisciplinary limb salvage team.

Follow-Up

ABI/TBI every 6–12 months; duplex surveillance for stents/bypasses; lifelong risk factor control.

Cardiovascular Disease - Related Articles